ABSTRACTS

CLICK ON LINK TO VIEW ALL ABSTRACT PRESENTED

001

 

DIABETES & STROKE IN 2006 HOSPITALIZED PATIENTS: AN ANALYSIS OF HEALTHCARE COST BY RACE AND GENDER

Baqar A. Husaini, PhD1, V. Cain, MA,1 Z. Samad, MPH, K.B. Merchant, BS1,

R.S. Levine, MD2, M. Moonis, MD3

002

Blood pressure and hypertension among the Dutch Africans and South Asians and British Africans and South Asians: A cross national comparative study

Agyemang C1, Bhopal R2, Zaninotto P3, Unwin N4, Nazroo J5, Kunst A1, Stronks K1

003

EFFICACY OF THE VASODILATING, SELECTIVE b-BLOCKER NEBIVOLOL AS AN ADD-ON TO OTHER ANTIHYPERTENSIVES IN OBESE PATIENTS

Keith C. Ferdinand, MD

004

EFFECT OF NEBIVOLOL IN OBESE AFRICAN AMERICAN PATIENTS WITH HYPERTENSION

Keith C. Ferdinand, MD

005

ETHNIC DIFFERENCES IN RESPONSE TO INITIAL TREATMENT WITH VALSARTAN MONOTHERAPY OR COMBINATION VALSARTAN/HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH STAGE 2 HYPERTENSION

JOHN M FLACK1, Drew Levy2, Amy Rudolph2

006

Inhibition of HIV1 replication and restoration of glucose, lipids, Haemoglobin levels and nitric oxide (NO) imbalance in HIV1 patients from Gabon

Maka G1, Loundou J1, Mavoungou PV1, Akoume Ndong MY1, Ongali B1, Mavoungou E1, Mavoungou D1.

007

Changes in Glutathione Metabolism in Hypertensive African-American Women

Hong Yang, Guang Shan, LiChun Zhou, Xinghua Lin and ZhongMao Guo

008

HEALTH LITERACY AND LANGUAGE PREFERENCE IN HISPANICS WITH CHRONIC KIDNEY DISEASE

CLAUDIA M. LORA, LYNN ACKERSON, CHERYL ANDERSON, MARINO BRUCE,  EUNICE CARMONA, BEN GERBER, EVA LUSTIGOVA, ANDREW NARVA, LISA NESSEL, SYLVIA E.  ROSAS, ASHWINI SEHGAL, SUSAN STEIGERWALT, JULIO VIJIL, ALAN S. GO, AND JAMES P. LASH

009

BUILDING PARTNERSHIPS IN URBAN COMMUNITIES THROUGH FOCUS GROUPS

DEBORAH E. JONES, Bessie Weaver, Wallace Johnson, Elijah Saunders

010

Delayed Diagnosis/Management of Primary Aldosteronism-help from the Web: a support group for patients struggling with this common cause of difficult-to-control high blood pressure

GRIM CE, HALL S, MURPHY V, PEARSON HM AND THE 500+ MEMBERS OF HYPERALDOSTERONISM AT YAHOOGROUPS.COM

011

Prevalence of HTN in an HIV Clinic in Nigeria:  An epidemic within an epidemic?

OFONDU EO, ONWUEGBUCHULAM RA, OSONDU CN, NWOGU R, OKORO W, GRIM CE

012

QUALITY IMPROVEMENT FOR BLOOD PRESSURE (BP) MEASUREMENT: EFFECT OF TRAINING ON TERMINAL DIGIT PREFERENCE IN AN URBAN INTERNAL MEDICINE CLINIC

DALMAR, AHMED MD; Caceres, Anthony, MD; Grim, Clarence MD; Grim, Carlene

013

EFFICACY OF AN AMLODIPINE/OLMESARTAN MEDOXOMIL (AML/OM)-BASED TITRATION REGIMEN IN OBESE OR NON OBESE PATIENTS WITH HYPERTENSION

HENRY PUNZI, MD1; Ali Shojaee, PharmD2; Jen-Fue Maa, PhD2, Nisha Patel, PharmD2

014

EFFICACY OF OLMESARTAN MEDOXOMIL (OM) AND HYDROCHLOROTHIAZIDE (HCTZ) IN ELDERLY (≥65 YEARS) PATIENTS WITH HYPERTENSION: A POST HOC ANALYSIS OF PATIENTS WITH ISOLATED SYSTOLIC HYPERTENS

DEAN J. KEREIAKES, MD;1 Jen-Fue Maa PhD;2 Robert Dubiel, PharmD;2 Ali Shojaee, PharmD;2

015

IMPACT OF RACE ON BP REDUCTION AND GOAL ACHIEVEMENT OF OLMESARTAN MEDOXOMIL-BASED TREATMENT IN PATIENTS WITH TYPE 2 DIABETES

JOEL M. NEUTEL, MD1; Andrew Lewin, MD2; Jen-Fue Maa, PhD3; Ali Shojaee, PharmD3; Robert Dubiel, PharmD3Shojaee, PharmD;2

016

THE COMBINATION OF AMLODIPINE + OLMESARTAN MEDOXOMIL PROVIDES NUMERICALLY GREATER REDUCTIONS IN BLOOD PRESSURE COMPARED WITH COMPONENT MONOTHERAPIES IN RACE AND ETHNIC SUBGROUPS

Suzanne Oparil, MD1; David Ramstad, MD2; Michael Melino, PhD3; James Lee, PhD3; Reinilde Heyrman, MD3

017

EFFICACY OF AN AMLODIPINE/OLMESARTAN MEDOXOMIL (AML/OM)-BASED TITRATION REGIMEN IN BLACK OR NON-BLACK PATIENTS WITH HYPERTENSION

DEAN J. KEREIAKES, MD1; Joel M. Neutel, MD 2; Ali Shojaee, PharmD3;

William F. Waverczak, MS3; Robert Dubiel, PharmD3; Jen-Fue Maa, PhD3

018

EFFICACY OF AN AMLODIPINE/OLMESARTAN MEDOXOMIL (AML/OM)-BASED TITRATION REGIMEN IN PATIENTS WITH OR WITHOUT DIABETES AND HYPERTENSION

Henry Punzi, MD1; Andrew Lewin, MD2; Thomas Littlejohn III, MD3; Ali Shojaee, Pharm D4; William F. Waverczak, MS4; Robert Dubiel, PharmD4; Jen-Fue Maa, PhD4

019

THE ASSOCIATION BETWEEN HEALTH LITERACY AND GLYCEMIC CONTROL AMONG MEXICAN AMERICAN DIABETICS WITH CHRONIC KIDNEY DISEASE: A PRELIMINARY REPORT FROM THE PASO DEL NORTE KIDNEY DISEASE STUDY (PNKDS)

Patrick Ragland, Natalia Vega, Athena Fester, Denise Vasquez, Tarek Alhamad, Sean Connery, Fernando Madero, Rodrigo Alfaro, Jiries Dahu, Fernanda Payan, Marcelo Chauvet, Patrick Tarwater, GERMAN T. HERNANDEZ, MD

020

Nebivolol in High-risk, Obese African Americans With Stage 1 hypertension: Effects on Blood Pressure, Nitric Oxide Bioavailability, and Vascular Function

Nadya Merchant1, MPH, PhD, Tahir Haque2, Charles D Searles1, MD, Anbu Pandian1, MD, Ibis Bridges2, Syed T Rahman2, MD, Keith C. Ferdinand1, MD, Bobby V Khan1, MD, PhD

021

The Metabolic Syndrome Does Not Effectively Identify Diabetes Risk in Black Africans: Results of a Pilot Comparison of Black Africans and African Americans                                                          

Luercio, MF, Ricks, M, Thomas, F, Imoisili, OE, Miller, BV, Avila, NA, SUMNER, AE

022

PREVALENCE AND PATTERN OF METABOLIC SYNDROME IS SIMILAR IN WEST AFRICANS AND AFRICAN AMERICANS

SUMNER AE, Zhou J, Doumatey A, Imoisili OE, Rotimi CN

023

RELATIONSHIP BETWEEN INFLAMMATION AND HYPERTENSION IN BLACKS

RALPH E. WATSON MD, Cristiane Pereira-Hicks MS, Kiran V. Sarikonda MD, Veera P. Kotaru MD, Gregory D. Fink PhD

024

A comparative study of prevalence and management of arterial Hypertension in the French Caribbean region and mainland France

Violaine Zizka, Nathalie Ozier-Lafontaine, Jocelyn Inamo

025

Faith-based DASH lifestyle program for hypertension control in African Americans church communities- Program overview

1Dodani S, 1Sullivan D, 2Rankins J, 1Mayo M, 3Appel L, 1Ely A & 4Ard J

026

THE IMPACT OF PATIENT EDUCATION AND PHYSICIAN EDUCATION ON BLOOD PRESSURE CONTROL

SAUNDERS E1, Johnson W1, Shaya F2, Weaver B1, Mullins C D2, Howard D1, Foster C1, Yan X2, Norman N2

027

THE IMPROVEMENT OF DIABETES CONTROL AND DISEASE PROCESS AWARENESS AS A RESULT OF FACE TO FACE VS. MAIL INTERVENTION AMONG PATIENTS WITH DIABETES MELLITUS

Reed Winston, PhD, MD3, Elijah Saunders, MD1; Fadia T. Shaya, PhD, MPH2;  Aurelia Laird, RN3; Zhiqiang K. Lu, BSPharm, PhD Candidate2; Faye Larkins, RN3; C. Daniel Mullins, PhD2; Shavonna Jolly,URS3; Wallace Johnson, MD1; Bessie Weaver , RN1